JANX Janux Therapeutics, Inc.
Healthcare$14.40-0.83%ClosedMarket Cap: $878.2M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$28.57
Target (Median)
$30.00
Target Range
$14.00 - $45.00
Upside from current price: 98.4%
Rating Distribution
2 Strong Buy13 Buy2 Hold0 Sell1 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-08 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-05-08 | Wedbush | maintain | Outperform | Outperform |
| 2026-05-08 | Guggenheim | maintain | Buy | Buy |
| 2026-04-28 | Jones Trading | maintain | Buy | Buy |
| 2026-04-20 | Barclays | downgrade | Underweight | Overweight |
| 2026-04-15 | UBS | downgrade | Neutral | Buy |
| 2026-02-27 | Guggenheim | maintain | Buy | Buy |
| 2026-02-27 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2026-01-20 | Clear Street | downgrade | Hold | Buy |
| 2026-01-16 | Piper Sandler | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-2.74 | $7.0M | 12 |
| Sun Dec 31 | $-3.37 | $18.7M | 13 |
| Mon Dec 31 | $-3.78 | $75.6M | 11 |
| Tue Dec 31 | $-3.10 | $145.4M | 5 |